Overview TTHX1114(NM141) in Combination With DWEK/DSO Status: Recruiting Trial end date: 2021-12-30 Target enrollment: Participant gender: Summary Open label, single-treatment, with a concurrent non-treatment control Phase: Phase 2 Details Lead Sponsor: Trefoil Therapeutics, Inc.